Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Hairy Cell × Immunohistochemistry × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Tongue Neoplasms 1 Stomach Neoplasms 1 Solid Tumors With High Expression of Nectin4 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Prostatic Neoplasms 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Gallbladder Neoplasms 1 Esophageal Neoplasms 1 Ependymoma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Rituximab 8 Vemurafenib 4 Cyclophosphamide 4 Cladribine 4 obinutuzumab 3 Specimen Handling 3 Diphenhydramine 3 Biopsy 3 Acetaminophen 3 ibrutinib 2 fludarabine phosphate 2 fludarabine 2 binimetinib 2 Lenalidomide 2 Dexamethasone 2 Calcium Dobesilate 2 CT-P10 2 Bendamustine Hydrochloride 2 venetoclax 1 tovorafenib 1 polatuzumab vedotin 1 pembrolizumab 1 immunotoxin HA22 1 encorafenib 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 cc-486 1 brexucabtagene autoleucel 1 auricularum 1 acalabrutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡